| Apoptosis/anti‐apoptosis |
Metabolism |
| BCL2A1 |
14.4 |
NM_004049 |
BCL2‐related protein A1 |
SLC7A5 |
4.7 |
AB018009 |
Solute carrier family 7 (cationic amino acid transporter) |
| TNAIP8 |
3.8 |
NM_014350 |
Tumour necrosis factor α‐induced protein 8 |
PPAP2B |
4.2 |
AB000889 |
Phosphatidic acid phosphatase type 2B |
| TNFAIP3 |
3.6 |
NM_006290 |
Tumour necrosis factor α‐induced protein 3 |
ASNS |
3.5 |
NM_001673 |
Asparagine synthetase |
| TRAF1 |
3.5 |
NM_005658 |
TNF receptor‐associated factor |
INDO |
3.3 |
M34455 |
Indoleamine‐pyrrole 2,3 dioxygenase |
| BIRC3 |
3.4 |
U37546 |
Baculoviral IAP repeat‐containing 3 |
GCH1 |
2.9 |
NM_000161 |
GTP cyclohydrolase 1 (dopa‐responsive dystonia) |
| CARD15 |
3.0 |
NM_022162 |
Caspase recruitment domain family, member 15 |
S100A3 |
2.8 |
NM_002960 |
S100 calcium binding protein A3 |
| RIPK2 |
2.5 |
AF027706 |
Receptor‐interacting serine‐threonine kinase 2 |
SDC4 |
2.6 |
NM_002999 |
Syndecan 4 (amphiglycan, ryudocan) |
| TRIB3 |
2.3 |
NM_021158 |
Tribbles homolog 3 (Drosophila) |
MSCP |
2.5 |
BE677761 |
Solute carrier family 25, member 37 |
|
|
|
|
GFPT2 |
2.5 |
NM_005110 |
Glutamine‐fructose‐6‐phosphate transaminase 2 |
| Adhesion molecules/receptors |
MT1X |
2.3 |
NM_002450 |
Metallothionein 1X |
| TNFAIP6 |
21.3 |
NM_007115 |
Tumour necrosis factor α‐induced protein 6 |
MTIE |
2.3 |
BF217861 |
Metallothionein 1E (functional) |
| TNFRSF1 |
5.0 |
NM_002546 |
Tumour necrosis factor receptor superfamily, member 11b |
PDLM4 |
2.3 |
AF153882 |
PDZ and LIM domain 4 |
| LLT1 |
4.7 |
NM_013269 |
C‐type lectin domain family 2, member D |
LIPG |
2.3 |
NM_006033 |
Lipase, endothelial |
| BDKRB2 |
4.7 |
NM_000623 |
Bradykinin receptor B2 |
KCNMB1 |
2.2 |
U61536 |
Potassium large conductance calcium‐activated channel |
| TNC |
4.5 |
NM_002160 |
Tenascin C (hexabrachion) |
OASL |
2.2 |
NM_00373 |
2′‐5′‐Oligoadenylate synthetase‐like |
| TNFRSF9 |
4.4 |
NM_001561 |
Tumour necrosis factor receptor superfamily, member 9 |
Miscellaneous |
| OLR1 |
4.4 |
AF035776 |
Oxidised low density lipoprotein (lectin‐like) receptor 1 |
TNFAIP2 |
9.7 |
NM_006291 |
Tumour necrosis factor α‐induced protein 2 |
| IL18R1 |
4.3 |
NM_003855 |
Interleukin 18 receptor 1 |
DD1T4 |
2.8 |
NM_019058 |
DNA‐damage‐inducible transcript 4 |
| E‐Selectin |
3.8 |
NM_000450 |
Selectin E (endothelial adhesion molecule 1) |
IFIT3 |
2.5 |
NM_001549 |
Interferon‐induced protein with tetratricopeptide repeats 3 |
| ICAM |
3.4 |
NM_000201 |
Intercellular adhesion molecule 1 (CD54) |
IFIT2 |
2.3 |
BE888744 |
Interferon‐induced protein with tetratricopeptide repeats 2 |
| ICOSL |
3.1 |
AL355690 |
Inducible T‐cell co‐stimulator ligand |
MOX2 |
2.2 |
H23979 |
CD200 antigen |
| CCRL2 |
3.0 |
AF015524 |
Chemokine (C‐C motif) receptor‐like 2 |
ZC3HV1 |
2.2 |
NM_020119 |
Zinc finger CCCH‐type, antiviral 1 |
| PDZK3 |
2.8 |
AF338650 |
PDZ domain containing 3 |
CDC42 |
2.1 |
AI754416 |
CDC42 effector protein (Rho GTPase binding) 3 |
| CD69 |
2.6 |
L07555 |
CD69 antigen (p60, early T‐cell activation antigen) |
MSCP |
2.1 |
NM_018579 |
Solute carrier family 25, member 37 |
| IFRG28 |
2.5 |
NM_022147 |
28kD Interferon responsive protein |
AIMI |
2.1 |
U83115 |
Absent in melanoma 1 |
| JAG1 |
2.3 |
U61276 |
Jagged 1 (Alagille syndrome) |
CHST5 |
2.1 |
N32257 |
Carbohydrate metabolism N‐acetylglucosamine metabolism |
| PTHLH |
2.2 |
BC005961 |
Parathyroid hormone‐like hormone |
NAV3 |
2.0 |
NM_014903 |
Neuron navigator 3 |
| EB13 |
2.2 |
NM_005755 |
Epstein‐Barr virus induced gene 3 |
ST5 |
2.0 |
NM_005418 |
Suppression of tumourigenicity 5 |
| VCAM |
2.2 |
NM_001078 |
Vascular cell adhesion molecule 1 |
FLJ23231 |
2.0 |
NM_025079 |
Zinc finger CCCH‐type containing 12A |
| CD83 |
2.1 |
NM_004233 |
CD83 antigen (immunoglobulin superfamily) |
|
|
|
|
| PDGFRA |
2.1 |
NM_006206 |
Platelet‐derived growth factor receptor α polypeptide |
Transcription factors/signalling |
| HRH1 |
2.1 |
D28481 |
Histamine receptor H1 |
NKX31 |
6.3 |
AF247704 |
Transcription factor related, locus 1 (Drosophila) |
| IL1R1 |
2.1 |
NM_000877 |
Interleukin 1 receptor, type I |
SOD2 |
5.7 |
AL050388 |
Superoxide dismutase 2, mitochondrial |
|
|
|
|
CEBPD |
5.6 |
NM_005195 |
CCAAT/enhancer binding protein (C/EBP), delta |
| Coagulation |
HIVER2 |
4.4 |
AL023584 |
Human immunodeficiency virus type I enhancer binding protein 2 |
| F3 |
3.3 |
NM_001993 |
Coagulation factor III (tissue factor) |
DSCR1 |
3.7 |
NM_004414 |
Down syndrome critical region gene 1 |
|
|
|
|
Transcription factors signalling continued RAPGEF5 |
3.4 |
NM_012294 |
Rap guanine nucleotide exchange factor (GEF) 5 |
| Cytokines/chemokines |
STC2 |
3.2 |
BC000658 |
Stanniocalcin 2 |
| CCL20 |
27.0 |
NM_004591 |
Macrophage inflammatory protein‐ MIP‐3 |
NCF4 |
2.9 |
NM_013416 |
Neutrophil cytosolic factor 4, 40 kDa |
| CXCL3 |
14.7 |
NM_002090 |
Chemokine (C‐X‐C motif) ligand 3 |
APOL3 |
2.7 |
NM_014349 |
Apolipoprotein L3 |
| CSF2 |
11.6 |
M11734 |
Colony stimulating factor 2 (granulocyte‐macrophage) |
SNFT |
2.6 |
NM_018664 |
Jun dimerisation protein p21SNFT |
| CX3CL1 |
10.5 |
NM_002996 |
Fractalkine |
RND1 |
2.6 |
U69563 |
Rho family GTPase 1 |
| CSF3 |
6.9 |
NM_000759 |
Colony stimulating factor 3 (granulocyte) |
MAP3K8 |
2.6 |
NM_005204 |
Mitogen‐activated protein kinase kinase kinase 8 |
| IL6 |
6.0 |
NM_000600 |
Interleukin 6 (interferon β2) |
FOXF1 |
2.5 |
NM_001451 |
Forkhead box F1 |
| CXCL5 |
5.6 |
AK026546 |
Chemokine (C‐X‐C motif) ligand 5 |
IRF1 |
2.5 |
NM_002198 |
Interferon regulatory factor 1 |
| IL1β |
5.1 |
NM_000576 |
Interleukin 1β |
MSC |
2.4 |
AF060154 |
Musculin (activated B‐cell factor‐1) |
| CXCL2 |
4.1 |
M57731 |
Chemokine (C‐X‐C motif) ligand 2 |
|
|
|
|
| FGF18 |
4.1 |
NM_003862 |
Fibroblast growth factor 18 |
RGS2 |
2.3 |
NM_002923 |
Regulator of G‐protein signalling 2, 24 kDa |
| CXCL1 |
4.0 |
NM_001511 |
Chemokine (C‐X‐C motif) ligand 1 |
STAT5A |
2.2 |
NM_003152 |
Signal transducer and activator of transcription 5A |
| LIF |
3.6 |
NM_002309 |
Leukaemia inhibitory factor (cholinergic differentiation factor) |
MEOX1 |
2.2 |
NM_004527 |
Mesenchyme homeo box1 |
| CXCL10 |
3.3 |
NM_001565 |
Chemokine (C‐X‐C motif) ligand 10 |
NFKB1 |
2.2 |
M55643 |
Nuclear factor of kappa light polypeptide gene enhancer |
| CXCL11 |
2.3 |
AF030514 |
Chemokine (C‐X‐C motif) ligand 11 |
ISG20 |
2.2 |
NM_002201 |
Interferon stimulated exonuclease gene 20 kDa |
| LTB |
2.3 |
NM_002341 |
Lymphotoxin β (TNF superfamily, member 3) |
ABTB2 |
2.2 |
AL050374 |
Ankyrin repeat and BTB (POZ) domain containing 2 |
| IL8 |
2.2 |
AF043337 |
Interleukin 8 |
|
|
|
|
| CCL5 |
2.1 |
NM_002985 |
Chemokine (C‐C motif) ligand 5 |
|
|
|
|
| CCL8 |
2.1 |
AI984980 |
Chemokine (C‐C motif) ligand 8 |
|
|
|
|
| PBEF1 |
2.0 |
BF575514 |
Pre‐B‐cell colony enhancing factor 1 |
|
|
|
|
| CSF1 |
2.0 |
M37435 |
Colony stimulating factor 1 |
|
|
|
|
